Healthcare / Health Information ServicesStockholm
$0.82
-0.02 (-2.38%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-13.4M · quality 51.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
8/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$73M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-51.8%
↓Gross Margin
112.3%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-5.8%
FCF CAGR
—
FCF margin
-23.5%
FCF / Net income
0.24x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $57.0M · net income $-54.9M · FCF $-13.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $57.0M | $57.0M | $55.7M | $89.2M | $68.3M |
| Net Income | $-54.9M | $-54.9M | $-16.1M | $10.0M | $5.9M |
| EBITDA | $-42.7M | $-42.7M | $-8.9M | $19.4M | $13.1M |
| EPS | -0.90 | -0.90 | -0.36 | 0.21 | 0.13 |
| Gross Margin | 112.3% | 112.3% | 110.8% | 105.8% | 107.8% |
| Operating Margin | -87.7% | -87.7% | -35.3% | 15.8% | 7.0% |
| Net Margin | -96.3% | -96.3% | -28.9% | 11.2% | 8.6% |
| Balance Sheet | |||||
| Debt/Equity | — | — | 0.03 | 0.01 | 0.02 |
| Current Ratio | 3.04 | 3.04 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-13.4M | $-13.4M | $-10.4M | $-16.7M | $-25.7M |
| Returns | |||||
| ROE | -51.8% | -51.8% | -15.9% | 8.6% | 5.5% |
| Valuation | |||||
| P/E | — | — | — | 125.02 | 270.65 |
| EV/EBITDA | — | — | — | 60.78 | 124.80 |
| P/B | 0.49 | 0.49 | 1.98 | 10.27 | 15.66 |
| Growth & Yield | |||||
| Revenue Growth | 2.5% | 2.5% | -37.6% | 30.7% | — |
| EPS Growth | -148.7% | -148.7% | -269.6% | 62.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-72.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.36 → -0.90
Residual
-72.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.